The latest update is out from Vor Biopharma ( (VOR) ).

VOR (Very High Frequency Omni-Directional Range) stations are ground-based navigation aids that use radio signals to guide aircraft, serving as a backup to GPS. While many VORs are being ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose ...

Vor Biopharma Inc. (VOR) closed the last trading session at $5.39, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

EDT Vor Bio (VOR)pharma trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

We recently published These 10 Stocks are Winning Big. Vor Biopharma Inc. (NASDAQ:VOR) is one of the best-performing stocks on Monday. Vor Biopharma extended its winning streak to a fourth consecutive ...

Telitacicept could generate $1.8 billion in U.S. sales if it captures 15% of the gMG market at $225K per patient. Vor will pay $125 million upfront to RemeGen, with milestone payments exceeding $4 ...

Vor Bio has handed Dallan Murray a swift return to the workforce. Weeks after being let go by Sarepta Therapeutics, Murray has landed the chief commercial officer post in Vor’s new-look C-suite.

CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...

Johnson & Johnson has teamed up with Vor Biopharma to study one of its bispecific antibodies in combination with technology designed to improve tolerability. Vor, which was founded by Siddhartha ...

Captain Vor is an iconic villain in Warframe and the first boss you’ll encounter in the game. Before the Isleweaver update, there were only two variants of Vor in the game: Captain Vor and Corrupted ...

CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...